David Hallengärd Email

Head Antibody Lead Generation . Mabtech

Current Roles

Employees:
132
Revenue:
$20.5M
About
Capture | Detect | Discover Mabtech is a Swedish biotech company founded in 1986. Our mission is to aid researchers to reach new frontiers and develop novel therapies, by supplying optimal immunoassays based on high-quality monoclonal antibodies and instruments. We develop and produce a wide range of monoclonal antibodies to cytokines and immunoglobulins. By selecting optimal matching pairs of capture and detection antibodies, we develop dependable sandwich assays such as ELISA, ELISpot and FluoroSpot kits. These kits are used to study immune responses in e.g. infectious disease, cancer, allergy, transplantation and as monitoring tools in vaccine trials. Our readers deliver unbiased spot analysis by combining an innovative algorithm with state-of-the-art hardware. Mabtech IRIS is our next-generation 4-color FluoroSpot/ELISpot reader enabling reliable multiplexing. Mabtech ASTOR is a reader with the same innovative and user-friendly technology for labs performing only ELISpot. Research can be challenging. We love to support your quest for answers. Please contact us, by phone, via e-mail, social media or in our forum, and we will do our best to assist you.
Mabtech Address
Augustendalstorget 9
Nacka Strand, null
Mabtech Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.